After Months Of Due Diligence, We Believe That Steep Hill Is At The Top Of Their Field, And Are True Pioneers Of The Space.

Journalists and Bloggers “We are grateful for the confidence this very respected group of investors has placed in us and our work at Steep Hill,” said David Lampach, CEO and Co-Founder. “We believe the valuation marijuana of this round has been made more attractive to investors due to recent legislative changes in California, Washington State and New Mexico.” Morgan and Emily Paxhia, Founding Partners of Poseidon Asset Management said, “We have been deeply involved in making strategic cannabis investments in preparation for such milestones as the Medical Marijuana Regulation and Safety Act of 2015 and believe the best returns on investment will be those companies that are best positioned in advance of such enactment Steep Hill is one of those companies.” Jmichaele Keller, Delft Blue Horizons Managing Director commented, “We were fortunate to learn about Steep Hill at the ArcView Investors Conference in April, and our relationship has only deepened over the last several months as the opportunities for testing have exploded. We see exciting new product differentiation in the testing market in the near future.” Phyto Managing Partner Larry Schnurmacher remarked, “Phyto is focused on providing capital to entrepreneurs, startups and operating businesses in the cannabis market we believe that all roads lead through testing in a regulated market and Steep Hill is a cornerstone investment for us.” Primex Clinical Laboratories CEO Oshin Harootoonian said, “We recognize that the future of the legalized cannabis market in California is going to require top-notch quality assurance testing. After months of due diligence, we believe that Steep Hill is at the top of their field, and are true pioneers of the space. We look forward to working closely with them as the cannabis industry matures in California.” For more information about cannabis testing or investing in the company, please visit the Steep Hill website: http://steephill.com ABOUT STEEP HILL Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the industry leader in cannabis testing and analytics. With labs in five statessoon to be six with Oregon launching in January 2016and a joint venture with the University of Technology in JamaicaSteep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in Californiathe first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann, QuantaCann2 and GenKit. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well. ABOUT DELFT BLUE HORIZONS Delft Blue Horizons B.V. is a Dutch family office, focused on discovering and investing in passionate entrepreneurs seeking Angel and Private Venture Capital funding where our depth of experience in Corporate Culture, Organizational Transformation, Entrepreneurial Finance, Business Intelligence, Agile Software Development and Digital Marketing can be leveraged to create a Fast Track to success. ABOUT PHYTO PARTNERS Phyto Partners is a venture capital fund that invests in businesses that operate in and around the burgeoning cannabis industry. The Phyto team provides strategic business resources to companies that participate in the business of Cannabis.

To read more visit http://www.prnewswire.com/news-releases/steep-hill-announces-current-investment-round-expires-on-december-31-2015-as-major-investors-and-strategic-partners-commit-to-invest-in-a-cannabis-industry-testing-leader-300175183.html?tc=socialpost